Crocs Discloses Q1 2023 Sales Data in 8-K Filing

TL;DR

**Crocs just dropped Q1 2023 sales data, showing strong growth in North America and international markets across both wholesale and direct-to-consumer channels!**

AI Summary

Crocs, Inc. filed an 8-K on February 16, 2024, disclosing information under Regulation FD and regarding financial statements and exhibits. The filing includes detailed sales data for its Crocs Brand segment in North America and International regions for Q1 2023 and Q1 2022, broken down by wholesale and direct-to-consumer channels. For example, North America Crocs Brand wholesale sales were $150.9 million in Q1 2023, up from $130.4 million in Q1 2022.

Why It Matters

This filing provides investors with a detailed look into Crocs' sales performance across different segments and channels, offering transparency into its operational health and growth drivers.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate risks.

Key Numbers

• $150.9 million — North America Crocs Brand Wholesale Sales (Reported for Q1 2023, showing growth from Q1 2022)
• $130.4 million — North America Crocs Brand Wholesale Sales (Reported for Q1 2022, for comparison with Q1 2023)

Key Players & Entities

• Crocs, Inc. (company) — Filer of the 8-K
• $150.9 million (dollar_amount) — North America Crocs Brand wholesale sales for Q1 2023
• $130.4 million (dollar_amount) — North America Crocs Brand wholesale sales for Q1 2022
• February 16, 2024 (date) — Date of 8-K filing
• Q1 2023 (date) — Period of reported sales data
• Q1 2022 (date) — Comparative period for reported sales data

FAQ

Key Financial Figures

• $0.001 — ch registered: Common Stock, par value $0.001 per share CROX The Nasdaq Global Select

Filing Documents

• crox-20240215.htm (8-K) — 109KB
• crox-20240215_d2.htm (EX-99.1) — 129KB
• 0001334036-24-000029.txt ( ) — 1070KB
• crox-20240215.xsd (EX-101.SCH) — 5KB
• crox-20240215_def.xml (EX-101.DEF) — 11KB
• crox-20240215_lab.xml (EX-101.LAB) — 44KB
• crox-20240215_pre.xml (EX-101.PRE) — 24KB
• crox-20240215_htm.xml (XML) — 334KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On February 15, 2024, Crocs, Inc. ("we" or "our") is filing this Current Report on Form 8-K to reflect changes to the presentation of a note to the consolidated financial statements as set forth in (i) our Quarterly Report on Form 10-Q for the period ended March 31, 2023, as filed with the Securities and Exchange Commission (the "SEC") on April 27, 2023 (the "Q1 2023 10-Q"), (ii) our Quarterly Report on Form 10-Q for the period ended June 30, 2023, as filed with the SEC on July 27, 2023 (the "Q2 2023 10-Q"), and (iii) our Quarterly Report on Form 10-Q for the period ended September 30, 2023, as filed with the SEC on November 2, 2023 (the "Q3 2023 10-Q"), to reclassify certain amounts to conform to our most recent period presentation shown within our Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 10-K"). To reflect the change in presentation, we have attached Exhibit 99.1 to this Current Report on Form 8-K to update the previously reported amounts in the Revenues footnotes as disclosed in our Q1 2023 10-Q, Q2 2023 10-Q, and Q3 2023 10-Q. Except for the changes described above, this Current Report on Form 8-K does not modify or update disclosures as presented in our 2023 10-K or our Q1 2023 10-Q, Q2 2023 10-Q, or Q3 2023 10-Q and does not reflect any changes, events, or activities occurring after the applicable filing date. We have not otherwise updated for activities or events occurring after the applicable dates these items were originally presented. The information in this Current Report on Form 8-K should be read in conjunction with the other information included in our 2023 10-K, Q1 2023 10-Q, Q2 2023 10-Q, and Q3 2023 10-Q. The information in this Item 7.01 and Exhibit 99.1 furnished hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deem

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Unaudited revised Revenues footnotes in the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023, and September 30, 2023. 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH XBRL Taxonomy Extension Schema Document. 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB XBRL Taxonomy Extension Label Linkbase Document. 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CROCS, INC. Date: February 15, 2024 By: /s/ Anne Mehlman Anne Mehlman Executive Vice President and Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR